Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00044629 · ClinicalTrials.gov registry record · Phase 2
Combined Behavioral/Pharmacological Therapy for Insomnia
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 162
- Enrollment target
NCT00044629 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 162 participants.
The verdict
NCT00044629, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 162 participants
- Enrollment target
Study Summary
This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
Interventions
- DRUG Placebo
- BEHAVIORAL Cognitive-Behavioral Therapy for Insomnia
- DRUG zolpidem tartrate (Ambien)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2001-09 |
| Est. Completion | 2006-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00044629
The ClinicalTrials.gov registry entry for NCT00044629 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 162 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00044629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00044629 about?
NCT00044629 is a clinical study titled "Combined Behavioral/Pharmacological Therapy for Insomnia". This study will determine how sleeping pills can be combined with nondrug treatments to maximize the benefits of therapy for insomnia.
What is the current status of trial NCT00044629?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 162 participants. The study started on 2001-09. Estimated completion is 2006-08.
What interventions are being tested in trial NCT00044629?
The interventions under investigation include: Placebo (DRUG), Cognitive-Behavioral Therapy for Insomnia (BEHAVIORAL), zolpidem tartrate (Ambien) (DRUG).
Who is sponsoring clinical trial NCT00044629?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.